FDA approves anti-obesity drug as first sleep apnea medication
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
The Washington Post6d
FDA approves weight-loss drug Zepbound to treat sleep apnea
“[Friday’s] decision likely opens the door to Medicare coverage of an anti-obesity medication a bit wider than when the FDA approved Wegovy for cardiovascular disease risk reduction early in ...
NYC’s health plan must cover anti-obesity drugs
Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...
Sandoz Boss Warns There’s a Climate Cost of Obesity Wonder Drugs
Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...
The American Journal of Managed Care5d
ICYMI: AHA 2024 Scientific Session Highlights
Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...
Bloomberg L.P.5d
Sandoz Boss Warns There’s a Climate Cost of Obesity Wonder Drugs
Richard Saynor wants to transform Sandoz Group AG into a world champion in copying leading-edge drugs, including anti-obesity and biological treatments, with the goal of bringing them to the masses.
Managed Healthcare Executive5d
ICER Finds Insurers Struggled to Provide Fair Access for Obesity Drugs
The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...